-
Apellis Announces Pegcetacoplan MAA Review Has Been Reset to Day 180 of Initial Assessment by European Medicines Agency (EMA)
26 Apr 2024 11:15 GMT
Decision by EMA follows recent judgment by the Court of Justice of the European Union regarding the organization of EMA’s expert groups
Apellis anticipates a CHMP opinion no later than July 2024
WALTHAM, Mass., April 26, 2024 (GLOBE NEWSWIRE) -- Apellis …
-
U.S. biotech leadership is rooted in strong IP protection
26 Apr 2024 11:13 GMT
… medicine,” says Hans Sauer, Vice President for Intellectual Property at the Biotechnology … global leader in medical, agricultural, industrial, and environmental biotechnology,” BIO VP Sauer …
-
Opinion: Solving academic medical centers’ existential crisis
26 Apr 2024 11:13 GMT
… The Association of American Medical Colleges reports that teaching … has long benefited academic medical centers, seeding ground- … 300 spin-off heath biotech and medical device companies (130 … in science and medicine today.
Academic medical centers must strive …
-
Krystal Biotech to Report First Quarter 2024 Financial Results on May 6, 2024
26 Apr 2024 11:00 GMT
… com. About Krystal Biotech, Inc.
Krystal Biotech, Inc. ( … biotechnology company focused on the discovery, development and commercialization of genetic medicines … medicines in respiratory, oncology, dermatology, ophthalmology, and aesthetics. Krystal Biotech …
-
PinkDx Launches With $40 Million Series a Financing to Develop Diagnostics Addressing Unmet Medical Needs for Women
26 Apr 2024 11:12 GMT
… investments in Genomic Health, Foundation Medicine and Veracyte.
Joe Cook, III … Series A funding from prominent biotechnology investors, including Catalio Capital Management … -to-develop-diagnostics-addressing-unmet-medical-needs-for-women-302127015.html …
-
Insilico Medicine's AI-designed drug ISM3412 receives FDA IND approval
26 Apr 2024 05:25 GMT
… -driven drug discovery company Insilico Medicine ("Insilico") announces that … Rao, MD, Chief Medical Officer of Insilico Medicine
MAT2A (methionine adenosyltransferase 2A … published a paper in Nature Biotechnology that discloses the raw experimental …
-
BME Seminar Series: Jie Song, PhD, UMass Chan Medical School- “Functional Shape Memory Tissue Grafts & Anti-Infective Implant Coatings”
26 Apr 2024 00:51 GMT
… of Biochemistry & Molecular Biotechnology
UMass Chan Medical School
Abstract: Facile surgical …
-
Inflation Reduction Act to have knock on effect on R&D, say biotech experts
25 Apr 2024 21:00 GMT
… curb inflation by allowing Medicare to negotiate prices … biotech and pharma companies, including reduced drug pricing for Medicare … Deals Database, US-headquartered biotechs saw 48% ($1.05bn … indication.
“From a biotech perspective, it increases the number …
-
This biotech startup got the biggest venture capital deal in San Diego so far this year
25 Apr 2024 20:52 GMT
… , but a few local biotechs still notched some impressive investment … ’re looking for targeted medicines to treat the source of … development costs down and make medicines work for more patients.
… with $157 million; and Mainstay Medical with $125 million.
The …
-
Check Up: Big breakthrough in acne treatment, and recent ASX biotech winners
25 Apr 2024 20:32 GMT
… 5% Gel is a prescription medicine used on the skin (topical … in June 2023.
How ASX biotechs performed over the past month …
-7%
$78,497,557
MVP
Medical Developments
0.545
-1%
-5% …
$126,018,748
OSL
Oncosil Medical
0.005
-29%
-12%
-41% …